Global Ganja Report

Brazil's limited medical marijuana program takes a step forward with new regulations allowing importation of THC products. Cultivation within the country, however, will be confined to "hemp"—that is, CBD-only strains. And even that is proceeding very slowly. The far-right government of Jair Bolsonaro meanwhile continues its hardline policies in the face of fast-escalating narco-violence.

Cannabis industry leaders have announced certification standards to promote corporate responsibility. The move appears to be prompted by some embarrassing scandals in the young industry. Activists are meanwhile raising more far-reaching demands for drug war "reparations." 

Yet again, a scientific study linking cannabis use to psychiatric maladies gets widespread and sensationalistic media play. And once again, the assumptions behind the study are questionable, and the findings are further distorted by irresponsible reportage.

Does daily cannabis use, especially of high-potency "skunk" strains, lead to an increased risk of developing psychosis? Based on recent media coverage, you can be forgiven for thinking so. But you should really take a closer look before you believe the hype.

Latin America is at the forefront of the global wave of cannabis law reform, according to a new report from a DC-based industry analyst. New Frontier Data sees a $9.8 billion market in the region, with big expansion potential for both exports and serving local consumption. 

An international network of non-governmental organizations has submitted a "shadow report" to the United Nations, calling the war on drugs a "spectacular failure"—and calling on the world's governments to reconsider it. The report takes heart from the growing official tolerance of cannabis in several countries around the world, but warns of escalating and horrific repression in the name of drug enforcement in several others. Will the UN take heed when it revisits the question of drug policy in 2019?

Over the past two years, the Latin American cannabis industry has "emerged from the shadows" to command the attention of international firms and investors. Legal cannabis sales within the region are on track to reach $125 million in 2018—but that figure is expected to rise to $12.7 billion by 2028.

As the UN General Assembly met in New York, President Trump issued a "Global Call" to renew the war on drugs—to the dismay of activists and dissenting nations. But the UN itself has a contradictory cannabis policy—with some agencies recognizing its efficacy as medicine and others backing the prohibitionist doctrine of the Single Convention treaty.

Oakland-based cannabis industry research firm ArcView Group has released a new study, ambitiously entitled "The Road Map to a $57 Billion Worldwide Market." It provides a sweeping overview of recent progress and future prospects for legal or medical herb across the globe. But it also warns that, due to continued legal restrictions and bureaucratic overstretch, the market is in most areas bottlenecked from achieving its potential.